Skip to main content
. 2017 May 16;14(5):e1002299. doi: 10.1371/journal.pmed.1002299

Fig 3. Histogram of the distribution of the number of recurrent P. vivax infections occurring during the 1-y follow-up period.

Fig 3

AL, artemether-lumefantrine; AL+PQ, artemether-lumefantrine + primaquine; CQ, chloroquine; CQ+PQ, chloroquine + primaquine.